Panadol Baby suppositories rectal

Country: Armenja

Lingwa: Ingliż

Sors: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Ingredjent attiv:

paracetamol

Disponibbli minn:

Farmaclair

Kodiċi ATC:

N02BE01

INN (Isem Internazzjonali):

paracetamol

Dożaġġ:

125mg

Għamla farmaċewtika:

suppositories rectal

Unitajiet fil-pakkett:

(10/2x5/)

Tip ta 'preskrizzjoni:

OTC

L-istatus ta 'awtorizzazzjoni:

Registered

Data ta 'l-awtorizzazzjoni:

2018-09-17

Karatteristiċi tal-prodott

                                SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
Panadol Baby 125 mg Suppositories
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each suppository contains Paracetamol Ph. Eur. 125 mg.
3.
PHARMACEUTICAL FORM
Suppository
4.
CLINICAL PARTICULARS
4.1.
THERAPEUTIC INDICATIONS
Symptomatic treatment of pain from mild to moderate intensity and / or
fever.
Panadol Baby suppositories 125 mg are for children aged 6 to 18 months
(with body weight of 7 to 10 kg).
4.2.
POSOLOGY AND METHOD OF ADMINISTRATION
For rectal administration only.
Clean hands and free up the suppository from plastic coat. Carefully
get in the
suppository rectally (mostly after purgative enema or physical
defecation). Convenient
administration is achieved by lateral position of baby with moving up
the leg to
abdomen.
Average single dose depends on child weight and equal to 10 – 15 mg/
kg, have to
be taken 3-4 times 6 hours throughout the 24-hour period.
Maximum daily doses should not exceed 60 mg / kg.
Children weight from 7 till 10 kg (aged 6-18 months): 1suppositories
(125 mg) as
required every six hours. Not more than four doses in any 24 hour
period.
Maximum duration of continued use without medical advice: 3 days.
Do not exceed the stated dose. Stop taking this medicine and consult
your doctor in
case of the therapeutic effect is absent.
Due to potential toxicity of such medicine rectal administration of
paracetamol
should be as short as possible.
Use the lowest recommended doses to achieve effect.
4.3.
CONTRAINDICATIONS

Hypersensitivity to paracetamol or any of the other constituents;

Hepatocellular insufficiency;

Recent inflammation or bleeding in rectum;
4.4.
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Contains paracetamol. Do not use with any other
paracetamol-containing products. The concomitant use
with other products containing paracetamol may lead to an
overdose.
Paracetamol overdose may cause liver failure which can
lead to liver transplant or death.
Underlying liver disease increases the risk of paracetamolrelat
                                
                                Aqra d-dokument sħiħ
                                
                            

Dokumenti f'lingwi oħra

Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Russu 17-09-2018

Fittex twissijiet relatati ma 'dan il-prodott